91
Views
32
CrossRef citations to date
0
Altmetric
Cardiac & Vascular Function

Effects of the New Antiarrhythmic Peptide ZP123 on Epicardial Activation and Repolarization Pattern

, , &
Pages 371-378 | Published online: 11 Jul 2009

References

  • Dhein S, Krüsemann K, Schaefer T (1999). Effects of the gap junction uncoupler palmitoleic acid on the activation and repolarization wavefronts in isolated rabbit hearts. Br J Pharmacol 128: 1375–1384.
  • Dhein S, Tudyka T (1995). Therapeutic potential of antiarrhythmic peptides. Cellular coupling as a new antiarrhythmic target. Drugs 49: 851–855.
  • Dhein S, Manicone N, Müller A, Gerwin R, Ziskoven U, Irankhahi A, Minke C, Klaus W (1994). A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn Schmiedeberg's Arch Pharmacol 350: 174–184.
  • Müller A, Schaefer T, Gottwald M, Tudyka T, Linke W, Klaus W, Dhein S (1997). Effect of the antiarrhythmic peptide AAP10 on cellular coupling. Naunyn Schmiedeberg's Arch Pharmacol 356: 76–82.
  • Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S (2002). Pharmacological modulation of Gap Junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J 16: 1114–1116.
  • Dhein S, Weng S, Grover R, Tudyka T, Gottwald M, Schaefer T, Polontchouk L (2001). Protein kinase C? mediates the effect of antiarrhythmic peptide on gap junction conductance. Cell Commun Adhesion 8: 257–264.
  • Grover R, Dhein S (2001). Structure-activity relationships of novel peptides related to the antiarrhythmic peptide AAP10 which reduce the dispersion of epicardial action potential duration. Peptides 22: 1011–1021.
  • Kjølbye AL, Knudsen CB, Jepsen T, Larsen BD, Petersen JS (2003). Pharmacological characterization of the new stable antiarrhythmic peptide analogue ZP123: In vivo and in vitro studies. J Pharmacol Exp Ther 306: 1191–1199.
  • Xing D, Kjolbye AL, Nielsen MS, Petersen JS, Harlow KW, Holstein-Rathlou N-H, Martins JB (2003). ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol 14: 510–520.
  • Dhein S, Müller A, Gerwin R, Klaus W (1993). Comparative study on the proarrhythmic effects of some antiarrhythmic agents. Circulation 87: 617–630.
  • Lesh MD, Pring M, Spear JF (1989). Cellular uncoupling can unmask dispersion of action potential duration in ventricular myocardium. Circ Res 65: 1426–1440.
  • Kuo CS, Munakata K, Reddy CP, Surawicz B (1983). Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 67: 1356–1367.
  • Arisi G, Macchi E, Baruffi S, Spaggiari S, Taccardi B (1983). Potential field on the ventricular surface of the exposed dog heart during normal excitation. Circ Res 52: 706–715.
  • Wit AL, DillonSM(1993). Anisotropic reentry. In Cardiac Mapping. Shenasa M, Borggrefe M, Breithardt G, eds., pp. 127–154. Futura Publishing Company, Mount Kisco, NY.
  • Hofmann J (1997). The potential for isoenzyme-selective modulation of PKC. FASEB J 11: 649–669.
  • Buchanan JW, Saito T, Gettes LS (1985). The effects of antiarrhythmic drugs, stimulation frequency and potassium-induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium. Circ Res 56: 696–703.
  • Joyner RW (1982). Effects of the discrete pattern of electrical coupling on propagation through an electrical syncytium. Circ Res 50: 192–200.
  • Weingart R, Maurer P (1988). Action potential transfer in cell pairs from adult rat and guinea pig ventricles. Circ Res 63: 72–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.